MR Spectroscopic Imaging provides the ability to assess the abundance and spatial distribution of several neurometabolites, which are characteristic for pathophysiological processes related to the formation and development of Multiple Sclerosis lesions. In presented work we aimed to compare the detectability of metabolic changes in MS lesions for three different in-plane resolutions of MRSI, i.e. 2.2×2.2 mm2, 3.4×3.4 mm2 and 6.8×6.8 mm2. Our results suggest that the vast majority of metabolic changes in MS cannot be reliably assessed using MRSI with typical matrix sizes of 24x24 to 32x32. With ultra-high spatial resolution (2.2x2.2 mm2 in-plane) even very small MS lesions can be well resolved.